The final week of February, 2019 (Feb. 25 - Mar 1), iLab Operations Software will be conducting an internal event and will be staffed at significantly reduced levels. iLab Support will prioritize critical issues first (i.e. issues that prevent key workflows from completing) and to escalate an issue, please add "Urgent" to the ticket/ email subject or press "1", when prompted, on the iLab Support phone (regional numbers can be found here). Regular support tickets will be monitored periodically and processed in order of submission starting March 4th, 2019. During this time, you can also refer to the iLab Help Site and iLab Status Page for site information. Please note that this will not affect standard Core Facility Operations.

Evaluate in vivo efficacy of agents either alone or in combination with standard chemotherapy regimens against murine tumors, human tumor xenografts and transgenic mouse models of human cancer.

Compound delivery:

Formulated compounds for in vivo delivery using variety of commonly used vehicles and are administered by number of routes, including oral gavage, intraperitoneal, intravenous and by food and/or drinking water.

Rodent toxicology:

Closely work with principal investigators to determine max-tolerated dose after single dose, or repeat-dose toxicity studies in novel drug applications for cancer treatments on rodents.